Naoko Inomata
Overview
Explore the profile of Naoko Inomata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
499
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watanabe H, Takahagi S, Hayama K, Fukunaga A, Nakagawa Y, Inomata N, et al.
Int J Dermatol
. 2024 Nov;
64(2):349-358.
PMID: 39489861
Background: Chronic spontaneous urticaria (CSU) exhibits notable responsiveness to omalizumab (OMA). The prognosis and subsequent therapeutic strategies warrant comprehensive exploration in cases exhibiting inadequate responses to OMA. Methods: We conducted...
2.
Fukunaga A, Kakei Y, Murakami S, Kan Y, Masuda K, Jinnin M, et al.
Front Immunol
. 2024 Oct;
15():1441478.
PMID: 39351222
Background: For treating patients with refractory chronic spontaneous urticaria (CSU) resistant to standard doses of 2 generation H1-antihistamines (H1AH) the International and Japanese guidelines recommend increasing H1AH dose. The latter...
3.
Yamaura M, Iwahashi Y, Hashimoto E, Miura J, Murayama Y, Koshikawa S, et al.
Case Rep Dermatol Med
. 2024 Sep;
2024:1057957.
PMID: 39296428
Carmine is an aluminium and/or calcium-chelated complex form of carminic acid (CA), which is derived from the extract (cochineal), and is globally used as a red-colourant in foods and cosmetics....
4.
Izumi T, Teramoto Y, Kamimura A, Doi R, Takai S, Mori T, et al.
J Dermatol
. 2023 Nov;
51(2):271-279.
PMID: 38009848
Cutaneous squamous cell carcinoma is usually treated with surgery; however, locoregionally advanced cutaneous squamous cell carcinoma can be difficult to resect. Although recent guidelines from Western countries recommend using anti-programmed...
5.
Hagihara E, Ito H, Okamoto T, Inomata N
J Dermatol
. 2023 Jul;
50(11):e386-e387.
PMID: 37401037
No abstract available.
6.
Suzuki M, Koshikawa S, Watanabe H, Inomata N, Yamaguchi Y, Aihara M, et al.
J Dermatol
. 2022 Dec;
50(4):536-540.
PMID: 36540013
Osteopontin (OPN) was initially described as a protein involved in bone metabolism, but the roles played by OPN in the immune system and allergic reactions have attracted increasing attention. Here,...
7.
Lee E, Kiuchi Y, Inomata N, Sueki H
J Dermatol
. 2022 Sep;
50(3):387-392.
PMID: 36121111
CD134/OX40, a member of the tumor necrosis factor receptor superfamily, is a cell-specific receptor for human herpesvirus 6 (HHV-6) variant B. Patients with drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia...
8.
Bizjak M, Kosnik M, Dinevski D, Thomsen S, Fomina D, Borzova E, et al.
Qatar Med J
. 2022 Aug;
2022(2):19.
PMID: 35909392
The diagnosis of typical cold urticaria (ColdU) relies on whealing in response to local cold stimulation testing (CST). It can also manifest with cold-induced anaphylaxis (ColdA). Till date, it is...
9.
10.
Bizjak M, Kosnik M, Dinevski D, Thomsen S, Fomina D, Borzova E, et al.
Allergy
. 2022 Mar;
77(7):2224-2229.
PMID: 35258111
No abstract available.